Signal Detection and Regulatory Expectations
Short course
In The Cavendish Hotel, London
Description
-
Type
Short course
-
Level
Intermediate
-
Location
The cavendish hotel, london
-
Class hours
8h
-
Duration
2 Days
Featuring signal evaluation for both innovator and generic products under the newly revised Module IX Signal Management and quantitiive assessments.
Increasingly the most common critical findings in Regulatory Inspections are being given for signal detection and management – so the need to identify potential signals and risks in patients has never been greater. The protection of patients through robust and clear methodologies for signal detection amidst the ever increasing regulations requires that Companies need to have trained and competent staff to perform such activities. This course will provide a detailed overview of all aspects of safety reviews and signal detection within a Company and will cover signal evaluation for both innovator and generic products under the newly revised Module IX Signal Management and quantitative assessments.
Facilities
Location
Start date
Start date
Start date
About this course
This course will be of interest to those working in drug safety/pharmacovigilance as well as Regulatory personnel responsiblse for amending the labelling for products and for the production of the CCSI/DCSI.
Reviews
Subjects
- Risk
- Evaluation
- Staff
- IT risk
- Regulations
- Signal processing
- Signal Detection
- Management
- Medical
- Pharma
Teachers and trainers (1)
Graeme Ladds
Director, PharSafer
Course programme
Increasingly the most common critical findings in Regulatory Inspections are being given for signal detection and management – so the need to identify potential signals and risks in patients has never been greater. The protection of patients through robust and clear methodologies for signal detection amidst the ever increasing regulations requires that Companies need to have trained and competent staff to perform such activities. This course will provide a detailed overview of all aspects of safety reviews and signal detection within a Company and will cover signal evaluation for both innovator and generic products under the newly revised Module IX Signal Management and quantitative assessments.
Benefits in attending- Clarify the EU regulatory requirements for signal detection
- Understanding the new frequency requirements for safety review
- How to use the Eudravigilance quantitative signal tool
- Understand the safety review cycle and the safety review meeting and process
- Discuss safety communication – the CCSI/SCSI and labelling
- Gain a better understanding of risk benefit analysis – benefit-risk assessments and benefit-risk outcomes
This course will be of interest to those working in drug safety/pharmacovigilance as well as Regulatory personnel responsiblse for amending the labelling for products and for the production of the CCSI/DCSI.
Additional information
Signal Detection and Regulatory Expectations